1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea , CAS No.1443242-46-3, Inhibitor of mitogen-activated protein kinase 11;Inhibitor of mitogen-activated protein kinase 12;Inhibitor of mitogen-activated protein kinase 13;Inhibitor of mitogen-activated protein kinase 14
1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea , CAS No.1443242-46-3, Inhibitor of mitogen-activated protein kinase 11;Inhibitor of mitogen-activated protein kinase 12;Inhibitor of mitogen-activated protein kinase 13;Inhibitor of mitogen-activated protein kinase 14
AM9K4SZ3XK|CHF-6297|p38-|A MAPK-IN-5|UNII-AM9K4SZ3XK|CHEMBL5202475|1443242-46-3|compound 4e [PMID: 35546685]|Urea, N-(1'-(2-(dimethylamino)ethyl)-3-(1,1-dimethylethyl)(1,4'-bi-1H-pyrazol)-5-yl)-N'-((1S,4R)-1,2,3,4-tetrahydro-4-((3-((2S)-2-methyl-1-piperid
Specifications & Purity
Moligand™
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of mitogen-activated protein kinase 11;Inhibitor of mitogen-activated protein kinase 12;Inhibitor of mitogen-activated protein kinase 13;Inhibitor of mitogen-activated protein kinase 14
1.Armani E, Capaldi C, Bagnacani V, Saccani F, Aquino G, Puccini P, Facchinetti F, Martucci C, Moretto N, Villetti G et al.. (2022) Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases.. J Med Chem, 65 (10):(7170-7192). [PMID:35546685]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.